Katerina Jazbec Gradišar,Klemen Žiberna,Polonca Mali et al.
Katerina Jazbec Gradišar et al.
Background and objectives: Although COVID-19 convalescent plasma (CCP) has been successfully used to treat several viral infections, its effectiveness in neutralizing severe acute respiratory syndrome coronavirus 2 (SARS-...
Association between group B major ABO-incompatible platelet or plasma transfusion and severe allergic reactions: A nationwide haemovigilance analysis suggesting a role for α-gal syndrome. A Biomedical Excellence for Safer Transfusion Collaborative study [0.03%]
血型不兼容的B群血小板或血浆输注与严重过敏反应之间的关联：来自全国血液 vigilance 的分析提示α- gal 综合征的作用。一个生物医学卓越安全输血合作研究项目的一项研究
Lucile Malard,Cléo Beuscart,Luc de Chaisemartin et al.
Lucile Malard et al.
Background and objectives: Severe transfusion reactions to group B-incompatible platelets and plasma possibly related to the α-gal syndrome (AGS) have been recently described. AGS is a potentially severe Immunoglobulin E...
Denese C Marks
Denese C Marks
Editorial
Vox sanguinis. 2025 Oct 29. DOI:10.1111/vox.70116 2025
Pathogen inactivation of red cell concentrates and whole blood: II. In vivo human recovery studies, clinical trials and future directions [0.03%]
红细胞和全血的病原体灭活：II.体内恢复研究、临床试验及未来方向
Pieter F van der Meer,Jose A Cancelas,Thomas R L Klei
Pieter F van der Meer
Three technologies are currently under active development for pathogen inactivation of red cell concentrates or whole blood (WB): the Intercept technology using S-303 as an inactivating chemical; the Theraflex technology using UV-C illumina...
Including patient insights to improve the information materials provided to serum eye drop recipients [0.03%]
纳入患者观点以改善免疫耐受性眼药水接受者的信息资料
Carley N Gemelli,Phillip Mondy,Athina Kakkos et al.
Carley N Gemelli et al.
Background and objectives: Severe dry eye disease is a commonly diagnosed condition that can be treated with serum eye drops (SEDs). SEDs are manufactured from the serum obtained from whole-blood donation. Patient informa...
Maha A Badawi
Maha A Badawi
Blood transfusions are vital in health care, yet maintaining an adequate and safe blood supply remains a significant challenge. To address blood donation-associated challenges, this review explores how integrating artificial intelligence (A...
Pathogen inactivation of red cell concentrates and whole blood: I. History, technologies and in vitro product preservation studies [0.03%]
辐照和体外保存红细胞及全血：理化方法、历史及技术进展
Pieter F van der Meer,Jose A Cancelas,Thomas R L Klei
Pieter F van der Meer
The application of technologies to inactivate pathogens in pooled plasma products is nowadays the standard. The number of blood centres applying these technologies to platelet concentrates is steadily increasing. However, pathogen inactivat...
RhD-negative red blood cell use and conservation strategies in the Region of Southern Denmark [0.03%]
丹麦南部地区RhD阴性红细胞的使用及节约策略
Emil Ainsworth Jochumsen,Kjell E Titlestad,Ulrik Sprogøe et al.
Emil Ainsworth Jochumsen et al.
Background and objectives: Suboptimal use of RhD-negative red blood cells (RBCs) can lead to reduced inventories of this scarce resource. Prevention of D-alloimmunization is particularly important for RhD-negative females...
A scoping review of grey zone use for transfusion-transmitted infection screening among blood donors [0.03%]
关于献血者输血传播感染筛查中应用检测“灰区”的文献回顾
Rahul Chaurasia,Suhasini Sil,Chanchi Khiamniungan et al.
Rahul Chaurasia et al.
Background and objectives: Screening for transfusion-transmitted infections (TTIs) among blood donors is done using qualitative screening assays. Screening values that are close to cut-off values lie in the uncertainty zo...